Tuesday, 12th November COSA Annual Scientific Meeting 2013

-Welcome to the Country

- Official Opening, His Excellency Rear Admiral Kevin Scarce AC CSR RANR, Governor of South Australia

Lunchtime Meetings                                                                                                   

COSA Psycho-oncology Group AGM (Hall C)

COSA Cancer Pharmacists Group AGM (Hall D)

COSA Clinical Trials and Research Professionals Group AGM (M1&2)

COSA Familial Cancer Group AGM (M10&11)

Co-Chairs: Sid Silva and Ken Pittman

• Ovarian cancer in the elderly - the role of surgery and systemic treatment - Christopher Steer
• Treatment of Lymphomas in Patients Over 65 yrs of Age - Mark Hertzberg
• Elderly Patients and glioma- navigating the gaps in the evidence - Elizabeth Hovey
• Anemia in the Elderly: New Wrinkles on an Old Problem - Harvey Cohen

• Psychosocial Distress Screening in Oncology: A Qualitative Study of Health Professionals. - Kylie Cheng
• Lung Cancer in Rural and Remote Aboriginal and Torres Strait Islander Communities in Queensland - Barbara Page
• An Audit and Evaluation of the Lung Cancer Journey: Metropolitan and Non - Metropolitan - Barbara Page
• Compliance with nutrition prescription in patients with Head and Neck Cancer undergoing radiotherapy: a descriptive study - Ka Hi (May) Mak

• DENOSUMAB induced Hypocalcaemia in Advanced cancers at the Top End; Severity and Management - Alison Buete
• Long-Term Survival in Patients with Metastatic Melanoma who Received Ipilimumab in Four Phase II Trials - Kevin Chin
• Survival Analysis with 5 years of Follow-Up in a Phase III Study of Ipilimumab and Dacarbazine in Metastatic Melanoma - Kevin Chin
• RCT of Colonic Stent Insertion vs. Surgical Decompression for Patients with Malignant Incurable Large Bowel Obstruction - Katie De-loyde
• Monitoring clinical studies – improving quality - Belinda Fazekas
• Evaluation of an Education Program to Facilitate Patient Adherence, Toxicity Monitoring and Promote Safety and Wellbeing in the Self Administration of Oral Chemotherapy in the Home Setting - Tina Griffiths
• A Drug-Interaction Study of Effects of Calcium and Magnesium Infusions on Oxaliplatin Pharmacokinetics, Motor Nerve Hyperexcitability and Acute Neurotoxicity Symptoms in Colorectal Cancer Patients - Catherine H Han
• Retrospective Review of Hypersensitivity Reactions to Paclitaxel with Oral Versus Intravenous Dexamethasone, Antihistamine and H2-Antagonist Premedication. - Michelle Hong
• Granulocytic Sarcoma of the Bladder as the Sole Manifestation of Acute Myelogenous Leukemia: a case report and literature review - Abdel Nasser Hosein
• Development of Guidelines to Inform the Content of Summarized Patient Information Forms (SPIFs) Regarding Cancer-Related, Clinical Trials - Chi-Yin Kao
• Survival of Patients with Resected Cerebral Metastases from Gastrointestinal Cancers - David Lau
• A Pilot Study of a Healthy Lifestyle Self-Management Intervention with Cancer Survivors - Sharon Lawn
• Late Effects of Oxaliplatin-induced peripheral Neuropathy (LEON) - Jaein Lee
• CHARM Utility study - Yeh Chen Lee
• Monitoring and treatment of hypomagnesaemia in patients receiving cetuximab - Bill Loukas
• Ipilimumab Retreatment Following Induction Therapy: The Expanded Access Program (EAP) Experience - Tracy Michener
• A Prospective Study of Anti-Mullerian Hormone (AMH) As a Potential Predictor of Chemotherapy-Induced Menopause: Preliminary Results. - Jessica Miller
• An introduction to ICCon - Inherited Cancer Connect Partnership - Gillian Mitchell
• Physical Activity (PA) Participation for Women with Ovarian Cancer - David Mizrahi
• Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes after Positive Sentinel Lymph Node Biopsy in Melanoma Patients: Westmead Melanoma Unit Experience and a Review of Literature   - Vinayak Nagaraja
• Metastatic central nervous system recurrence in breast cancer: Impact of tumour sub-type - Brent O'Carrigan
• The Prostate Cancer Journey: Results of an Online Survey of Men and their Partners. - Kevin O'Shaughnessy
• Impaired Sexual Function and Prostate Cancer; A Mixed Method Investigation into the Experiences of Men and their Partners - Kevin O'Shaughnessy
• Audit of Patient Selection and Protocols for Prostate Cancer Active Surveillance in South Australia - Lovelace Osei-Tutu
• Qualitative Results of the LEON study: Late Effects of Oxaliplatin-Induced Peripheral Neuropathy - Sunita Padman
• Incidence of gastrointestinal toxicity with capecitabine monotherapy in metastatic breast and metastatic colorectal cancer patients  - James Kuo
• Barriers to Recruitment for a Post-Cancer Fatigue Intervention Study - The TOPS Trial. - Carolina Sandler
• Effectiveness and safety of first-line ipilimumab (IPI) 3mg/kg therapy for advanced melanoma (AM): Evidence from a U.S. multisite retrospective chart review - Jingli Song
• Hypocalcaemia in patients with metastatic bone disease (MBD) receiving denosumab - Richard H De Boer
• Meta-Analysis of Progression-Free Survival Impact of Biological Therapy in Relapsed Metastatic Colorectal Cancer - David Chan

• Audit Versus Actual Recruitment in Palliative Care Clinical Trials - Belinda Fazekas
• Communication between Health Professionals and Cancer Patients about Integrative, Complementary and Alternative Therapies: Exploring Different Perspectives - Paul Katris
• Current Australian Research Activity Investigating Complementary and Integrative Therapies in Oncology: A Survey of COSA Members - Paul Katris
• Complementary and Alternative Medicines Use by Cancer Patients and the Role of the Drug Information Pharmacist. - Ben Stevenson
• Student Perceptions of a Consumer Led Discussion Group Format to Improve Awareness of the Patient Perspective - Josephine S Thomas
• A Randomised Controlled Trial to assess the impact of a cognitive dissonance intervention to alter attitudes and intentions to tan among young adults in Australia. - Elise Watson

• Inpatient Chemotherapy Service Improvement Project - Marliese Alexander
• Quit Or Quiet? High Smoking Prevalence, Low Disclosure Rates and Low Smoking Cessation Program Participation Rates among Cancer Patients - Marliese Alexander
• Palliative Car Referrals and Time Period between Last Chemotherapy and Death in Metastatic Breast Cancer Patients in North Queensland. - pawan bajaj
• Cancer Coping Online: Findings and lessons learned from a phase II RCT of an eHealth program for reducing cancer-distress. - Lisa Beatty
• COSA Position Statement - The Use of Complementary and Alternative Medicine by Cancer Patients - Paul Katris
• Analysis of Pharmacist role in Haematology and Oncology at Royal Darwin Hospital - Alison Buete
• Identifying and addressing the supportive care needs of the ‘complex’ patient with Multiple Myeloma within a Nurse Practitioner led service - Michael Cooney
• Victorian Patient Management Framework: Achievements and future directions - Jessica Delaney
• Navigating Indirect Utility Models in Cancer: Mapping the EORTC QLQ-C30 onto the EQ-5D - Brett Doble
• Assessing the Value of Precision Therapies in the Multi-Omics Era of Medicine - Brett Doble
• Community Oncology: Patients’ perspective on a rural Australian medical oncology outreach service - Mathew George
• Feasibility study of an oncology nurse practitioner model of care in a rural cancer setting - Afaf Girgis
• Service Mapping the Flow of Care for Chemotherapy Outpatients at Sir Charles Gairdner Hospital - Livia Haddow
• Development and implementation of a clinical cancer data collection system in WA - Angela Ives
• How acceptable and beneficial do clinicians think peer review of multidisciplinary cancer teams is? - Claire E Johnson
• Is the chemo ready yet?! Gaining efficiency in parenteral cancer chemotherapy supply at a large tertiary level hospital - Daniel McKavanagh
• Where to care for childhood cancer survivors? Survivor and oncology service provider perspectives                         - Jordana K McLoone
• Radiotherapy access in the West Hume region: any need for a local radiation facility? - Nur Hayati Mohd Alias
• Risk perception in medical imaging: Understanding the effect of two risk presentation formats on knowledge - Danielle M Muscat
• Forthcoming Prognostic Markers for Oesophageal Cancer: A Systematic Review and Meta-Analysis   - Vinayak Nagaraja
• An exploration of the relationship between funding and patient accrual to oncology clinical trials: Additional Funding Intervention Trial (AFIT) - Cat Parker
• An Estimate of the Rate of Participation by Adolescent and Young Adults (AYA) in Oncology Clinical Trials in Victoria: 2011 and 2012 - Cat Parker
• Celebrating 25 years of the Clinical Trials Management Scheme (CTMS): Victorian clinical trial activity, 1988-2013 - Cat Parker
• Mapping cancer pain screening, assessment and reassessment practices within one Australian health district: results from a baseline chart audit - Jane Phillips
• Exploring opiate errors in the specialist cancer and palliative care setting: perceptions of key stakeholders - Jane Phillips
• An Evidence-Based Estimation of Local Control and Survival Benefit of Radiotherapy for Colorectal Cancer - Jesmin Shafiq
• Peer Review of Multidisciplinary cancer teams: a pilot study - Neli Slavova-Azmanova
• It’s Not Just a Numbers Thing – Looking for Quality in MDMs - Katherine Simons
• Indigenous Patients with Metastatic Lung Cancer at the Royal Darwin Hospital: An Eleven Year Audit of Data Regarding Chemotherapy, Radiotherapy and Palliative Care. - Eswaran Waran
• Assessing cancer patients experiences of care: the Victorian experience. - Victoria White
• Development of a capability framework to support the provision of chemotherapy within a shared care model for children and adolescents with cancer - Chris Packer
• Working Together: An Integrated Model of Care for Cancer Services - Bridget Wislang
• The Challenges in Integrating Care Coordinators into Cancer Care – an Analysis of Australian Evaluation Data - Patsy Yates
• Does the Availability of a Local Service Change the Types of Patients Who Accesses Radiotherapy? An Investigation in the Western NSW Local Health District (WNSWLHD). - Sally M Yeo

Discussant: David Goldstein

• Evidence Confirming Intermittent Androgen Deprivation as Rational Standard-Of-Care Treatment for Metastatic Prostate Cancer: A Meta-Analysis of Pooled Data from 5405 Patients with Fixed Effect Modelling - Daniel Brungs
• Pancreatico-Duodenectomy With High Quality Results in a Medium Volume Centre. What Are the Australian Definitions of Low Volume - Donna Gillies
• How is Cancer Research Reported by the Cancer Council’s Cancer Daily News - Yaping Liu
• Safety and Efficacy of Esophageal Stents Preceding or During Neoadjuvant Chemotherapy for Esophageal Cancer: A Systematic Review and Meta-Analysis - Vinayak Nagaraja
• Colorectal cancer surgery rates in indigenous versus nonindigenous patients - Dannie Zarate

• Medicine(s) Matter(s) in the Older Patient: Understanding, Counselling and Health Literacy - Jenny Casanova
• Medicine Matters in the Older Cancer Patient: Drug Interactions and Toxicities - Alexandre Chan
• Medication Adherence  - Christine Carrington

• OPTiM: a randomised phase 3 trial of talimogene laherparepvec (T-VEC) vs subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of unresected stage IIIB/C and IV melanoma - Robert HI Andtbacka
• Prognostic Significance, Accuracy and Usefulness of Oncologists Estimates of Survival Time for Patients Starting First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (ANSCLC) - Belinda E Kiely
• Treatment Outcomes of Rapid Desensitisation Protocols for Chemotherapeutic Agents and Monoclonal Antibodies following Hypersensitivity Reactions. - James C Kuo
• Disease and Patient Characteristics related to Survival in a large population-based cohort of patients with Malignant Pleural Mesothelioma (MPM) - Anthony Linton
• Somatic Mutations in Metastatic Melanoma in a large cohort of Australian patients   - Megan Lyle
• Prognostic Value of Early Objective Tumor Response (EOTR) to  First Line Systemic Therapy in Metastatic Colorectal Cancer (Mcrc): Individual Patient Data (IPD) Meta-Analysis of Randomized Trials from the ARCAD Database - Dirkje W Sommeijer

The Luminous awards will be presented from 5:50pm in Theatrette 1